Cargando…
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
BACKGROUND: The aim of this study was to investigate the expression of the nuclear receptor PPARγ, together with that of the cyclooxygenases Cox-1 and Cox-2, in breast cancer (BC) tissues and to correlate the data with several clinicobiological parameters including patient survival. METHODS: In a we...
Autores principales: | Shao, Wanting, Kuhn, Christina, Mayr, Doris, Ditsch, Nina, Kailuwait, Magdalena, Wolf, Verena, Harbeck, Nadia, Mahner, Sven, Jeschke, Udo, Cavaillès, Vincent, Sixou, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035771/ https://www.ncbi.nlm.nih.gov/pubmed/32085795 http://dx.doi.org/10.1186/s12967-020-02271-6 |
Ejemplares similares
-
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
por: Shao, Wanting, et al.
Publicado: (2021) -
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer
por: Shao, Wanting, et al.
Publicado: (2020) -
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients
por: Shao, Wanting, et al.
Publicado: (2022) -
Prognostic Relevance of RIP140 and ERβ Expression in Unifocal Versus Multifocal Breast Cancers: A Preliminary Report
por: Müller, Katharina, et al.
Publicado: (2019) -
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
por: Jeschke, Udo, et al.
Publicado: (2019)